Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial - Wikidata - wikimedia - TriplyDB

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

http://www.wikidata.org/entity/Q28256871

about

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Clinical and economic studies of eptifibatide in coronary stenting Coronary thrombus in patients undergoing primary PCI for STEMI: Prognostic significance and management Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis.The invasive assessment of coronary atherosclerosis and stents using optical coherence tomography: a clinical update Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous coronary intervention: analysis from the national cardiovascular data registry.Additive effect of in-hospital TIMI bleeding and chronic kidney disease on 1-year cardiovascular events in patients with acute coronary syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry.Tirofiban for myocardial infarction.Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures.Bivalirudin: a review of the pharmacology and clinical application.Safety of bivalirudin in patients with coronary artery disease.Bivalirudin for primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI trial.Myeloid-related protein-14 regulates deep vein thrombosis Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα.Post-operative thromboprophylaxis: new oral thrombin and factor X inhibitors and their place in clinical practice.Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy.Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention Bleeding avoidance strategies. Consensus and controversy Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.Point of care platelet activity measurement in primary PCI [PINPOINT-PPCI]: a protocol paper.Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention.Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty.Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Glycoprotein IIb/IIIa inhibitors and Unfractionated Heparin Monotherapy for patients undergoing percutaneous coronary intervention - A single centre observational study.Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction.Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes.Transulnar sheathless percutaneous coronary intervention during bivalirudin infusion in high-risk elderly female with non-ST segment elevation myocardial infarction.Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a network meta-analysis Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis.Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses.Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients.Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction.The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.Emerging drugs for acute myocardial infarction.Examining treatment of ST-elevation myocardial infarction: the importance of early intervention.The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention.Clinical applications of bivalirudin in the cardiac catheterization laboratory.Antithrombotic therapy in ST-segment elevation myocardial infarction.Emerging therapies for acute coronary syndromes

P2860

Q24202522-526E14E9-6E51-4AF3-8BB2-11CA5DD86662 Q24202999-2C44BF6E-A95A-4D47-B284-FBA9F1D42688 Q26830199-B25CD47F-136A-410C-B0CB-5149EE4C94CF Q26830317-727F4427-F5EB-4CB4-A396-7C29A8B34DB6 Q28512072-7904BADC-A798-4451-B5CB-79AB72ECCC16 Q30442855-21BF5344-7405-4A17-A635-B9207997E80B Q30660048-782B2E3B-4A97-480D-9C3C-33CD671F466C Q30815367-94EA91D9-D109-4A86-B038-4C40366775F2 Q33388527-175B2EEC-DA80-4070-AACC-DD0B7E08992A Q33391484-30A719D4-721C-42F9-84BF-3410BA4D19AD Q33392973-56799250-A144-45F4-BA2C-8B13A5319284 Q33397635-1C500131-46EE-4416-A76C-9A8C4EB690C7 Q33400450-2261534C-50FD-4AA0-8038-C48B3E3EC2AB Q33752316-7457472D-0458-4164-AF5E-1905EC23C8A9 Q33815771-09E7241D-D267-4C8A-9776-8BFD1472A574 Q34175551-DA3E7E6F-EDFA-4E3F-93A6-201377676E39 Q34242912-CB6B1FBA-A9B0-4E56-984E-8B4DB767D0F8 Q34254766-0DA1FAEF-0F77-415D-90FB-0AB10FD31C3B Q35079519-F05D765B-F080-4D8A-B9B4-2180956CD52A Q35114904-5CA965BE-7274-4404-86BC-2BA5FF43EF66 Q35141218-FEDC28C5-8524-42B5-B484-D9938D2F8F9F Q35193938-D9547251-EF62-40B0-A9F8-EBCBAFA983CD Q35808743-F80556BE-B216-4DD8-A88A-8F78D5ECDA11 Q36033582-6B3640D7-43F3-4491-9640-12CD14BE18C0 Q36060147-5B94F3F2-CDC6-4E7C-A863-B64807D1CD0C Q36062854-5EB88510-0EC5-40A3-8888-A940ACC5244F Q36151313-EF4938AF-68C4-4B5A-837A-7B650223772C Q36417654-1AC6D876-CCF6-4D08-8452-FEAA9BB7746D Q37225552-9DFCEDA7-F45D-4E37-912E-C44284C9DFFF Q37240704-15AF6213-33DD-4138-B307-D7B72AFD7014 Q37329447-EFB24A5D-FF49-4AFC-93F4-5EC853A6A9C0 Q37538067-F319A7A2-3B29-4888-9E94-D6C643F5D8EF Q37582213-3678C366-59C0-4CD1-B124-DCC28B636014 Q37599599-48FF673E-47EC-484E-85C2-D29283AACB45 Q37670190-9D6038AA-BAE5-4DFF-8DAC-A524306F50F7 Q37671422-66533269-02BE-44E9-B34B-4BF699BD2F01 Q37808230-6E710A6D-A4C0-424C-B049-B9C7798724AA Q37811622-8C1EE5EB-F0E9-4F4B-A610-A6C2F38A1BF1 Q37827870-4C113A7C-79E8-4158-AA37-1153967DD0CA Q37949587-EF6539DA-735A-40F9-ACC3-6B8B92FB6D7D

P2860

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

http://www.wikidata.org/entity/Q28256871

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Bivalirudin in patients underg ...... a randomised controlled trial

@ast

Bivalirudin in patients underg ...... a randomised controlled trial

@en

Bivalirudin in patients underg ...... a randomised controlled trial

@nl

type

label

Bivalirudin in patients underg ...... a randomised controlled trial

@ast

Bivalirudin in patients underg ...... a randomised controlled trial

@en

Bivalirudin in patients underg ...... a randomised controlled trial

@nl

prefLabel

Bivalirudin in patients underg ...... a randomised controlled trial

@ast

Bivalirudin in patients underg ...... a randomised controlled trial

@en

Bivalirudin in patients underg ...... a randomised controlled trial

@nl

P1433

Q28256871-0761D9D1-D848-4B7D-9B7C-C0171847A22B

P1476

Q28256871-8D3E776F-75F7-48A6-9DBD-55183861BEBC

P2093

Q28256871-0893D0CD-E1FF-4755-BE6F-CFE1991D9469

Q28256871-1CC6AB77-D6A2-4C51-9445-DF11A0712626

Q28256871-2B16333F-E7E7-421E-B9D9-55939352D4A7

Q28256871-31F21FBC-849C-4A03-83DE-89FE924527DB

Q28256871-372E109A-B0D4-453A-B5B1-525F4E5282E1

Q28256871-38F58999-C696-44BA-917D-23731B1A2445

Q28256871-43F8A2DB-74C8-409C-89A9-768A9C5A2430

Q28256871-6825E792-6783-4EC3-880E-B9F15AE7A090

Q28256871-85E62E9C-71DA-4DA2-8C22-6E9348690116

Q28256871-8DE104E1-3CE3-4AF9-9600-50D1797D27A0

P304

Q28256871-182E88B6-CB3D-4468-80D8-FB8F9CAC16E9

P31

Q28256871-CBD65718-CE2B-4684-A77B-C977C8D150D8

P3181

Q28256871-3FEC1783-0018-4E95-AB21-C68C6FD7BC90

P356

Q28256871-14D270C4-69B0-412E-B4AE-EA8B63FCAC37

P407

Q28256871-254463F4-03F8-4D53-B65A-AD5AC6AE92BE

P433

Q28256871-E0DB86F0-E17F-4F24-88F7-11A63DC2692D

P478

Q28256871-2B185DDF-BACD-4164-8CEB-384E6E30C958

P50

Q28256871-2D677CDF-DDCF-4BB6-BC3D-638845C89538

Q28256871-64279DA2-7B7C-41D7-AFF9-D1E368EFB1ED

Q28256871-9EB3BFF9-8F98-4134-864E-A427B014D3B0

Q28256871-C8943BD4-1F27-4A16-BF57-91DE83550757

P577

Q28256871-1E7A8B3B-1C18-4484-8FCF-A4289D926A36

P698

Q28256871-4D0BDE3F-1C93-427F-8BC4-82BB4CC4FA35

P921

Q28256871-151C3944-F983-411D-9C12-E5345B00F2E5

P3181

P356

S0140-6736(09)61484-7

P1433

P1476

Bivalirudin in patients underg ...... a randomised controlled trial

@en

P2093

Alexandra J Lansky

http://www.w3.org/2001/XMLSchema#string

Bernard J Gersh

http://www.w3.org/2001/XMLSchema#string

Bruce R Brodie

http://www.w3.org/2001/XMLSchema#string

Eugenia Nikolsky

http://www.w3.org/2001/XMLSchema#string

Franz Hartmann

http://www.w3.org/2001/XMLSchema#string

Giulio Guagliumi

http://www.w3.org/2001/XMLSchema#string

Gregg W Stone

http://www.w3.org/2001/XMLSchema#string

Helen Parise

http://www.w3.org/2001/XMLSchema#string

Jan Z Peruga

http://www.w3.org/2001/XMLSchema#string

Louise Gambone

http://www.w3.org/2001/XMLSchema#string

P304

1149-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4439750

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0140-6736(09)61484-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

9696

http://www.w3.org/2001/XMLSchema#string

P478

374

http://www.w3.org/2001/XMLSchema#string

P50

Bernhard Witzenbichler

George D Dangas

P577

2009-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19717185

http://www.w3.org/2001/XMLSchema#string

P921